Trupanion Logo
US8982021060
A117KY
TRUP

Trupanion

Cargando cotizaciones...

Previsión

El precio objetivo medio de los analistas es de 30,17 € (-3,61 %). La mediana es de 28,13 € (-10,13 %).

Comprar
  8
Mantener
  7
Vender
  0

Debates en la comunidad

Todavía no hay ninguna discusión sobre este activo.

Iniciar debate

  • Double downgrade drives Trupanion stock sharply lower

    The stock of Trupanion fell about 6.4% in morning trading after Piper Sandler cut its rating from "Overweight" to "Neutral" and lowered the price target from $45 to $32. Piper Sandler cited declining puppy vet visits and more costly, aging COVID cohorts as headwinds for premium growth and underwriting margins. A simultaneous downgrade by Zacks intensified the sell-off, while the new price target, near the current share price, signals only limited short-term upside. » Más en de.investing.com


  • Trupanion beats Q2 earnings forecast and highlights outlook for 2026

    Trupanion reported Q2/2026 earnings of $0.16 per share, beating the $0.1133 forecast, on revenue up 11% to $392.9m. Adjusted operating income from subscriptions rose 24% and subscription revenue grew 14% to $276.7m, while the number of insured pets increased 5% to 1.125m. The stock rose 6.7% after hours; management confirmed a 2026 revenue range of $1.584–1.601bn and adjusted operating income of $176–184m. Risks remain higher customer acquisition costs, ongoing veterinary price inflation and execution risks for new product options. » Más en de.investing.com


  • Trupanion reaches 52-week low at $24.13

    Trupanion shares fell to a 52-week low of $24.13 after losing about 34% over the past year and roughly 40% in recent months. For Q4 2025 the company reported earnings per share of $0.13 (forecast $0.16) and revenue of $376.9 million (+12% year over year), slightly beating expectations. Analysts cut price targets (Cantor Fitzgerald 42→34 USD, Stifel 35→31 USD) citing growth and scaling concerns, while InvestingPro signaled possible undervaluation and upside; Trupanion also announced a research collaboration with the Human Animal Bond Research Institute. » Más en de.investing.com


  • Trupanion falls to 52-week low of $24.30

    Trupanion shares hit a new 52-week low at $24.30, down about 31.7% year-to-date; the six-month performance is down nearly 38%. The company reported Q4 2025 EPS of $0.13 (expectation $0.16) on revenue of $376.9 million (+12% YoY, forecast $375.21 million). Analysts cut price targets (Cantor Fitzgerald 42 → 34 USD, Stifel 35 → 31 USD), citing growth and scaling issues, while InvestingPro sees an undervaluation of around 38% and expects profitability this year. Trupanion also announced a partnership with the Human Animal Bond Research Institute to support studies on human-animal relationships. » Más en de.investing.com


  • Trupanion hits 52-week low after sharp share decline

    Trupanion shares closed at $24.49, marking a 52-week low after declines of 33.06% over the past year, 43% in six months and 31% year-to-date. Investors are worried about slowing growth and competitive pressure in the pet insurance industry, although a PEG of 0.19 suggests possible undervaluation. In Q4 2025, Trupanion missed the EPS expectation (0.13 vs. $0.16) while revenue rose 12% to $376.9 million; a partnership with the Human Animal Bond Research Institute was also announced. » Más en de.investing.com

En 2022, Trupanion ya ha pagado 0,0078 € en dividendos. El último pago fue en abril de 2022.

Datos financieros de la empresa

En el último trimestre, Trupanion tuvo unos ingresos de 358,08 M € y un beneficio neto de 8,19 M €
(EUR) septiembre de 2026
YoY
Ingresos 358,08 M 14,52 %
Beneficio bruto 61,36 M 19,90 %
Beneficio neto 8,19 M 63,74 %
EBITDA 14,03 M 22,48 %

Datos fundamentales

Métrica Valor
Capitalización bursátil
1353,67 M €
Número de acciones
43,27 M
Máximo/mínimo de 52 semanas
35,27 € - 19,20 €
Dividendos No
Beta
1,30
Ratio P/E
56,52
Ratio PEG
0,76
Ratio P/B
3,77
Ratio P/S
0,96

Perfil de la empresa

Trupanion, Inc., junto con sus filiales, ofrece seguros médicos para gatos y perros con suscripción mensual en Estados Unidos, Canadá, Puerto Rico y Australia. La empresa opera en dos segmentos, Subscription Business y Other Business. Atiende a dueños de mascotas y a veterinarios. La empresa era conocida anteriormente como Vetinsurance International, Inc. y cambió su nombre a Trupanion, Inc. en 2013. Fue fundada en 2000 y tiene su sede en Seattle, Washington.

Nombre
Trupanion
CEO
Margaret Rosemary Maria Tooth
Sede Seattle, wa
Estados Unidos
Sitio web
Sector
Finanzas
Industria
Seguros
Salida a bolsa
18/07/2014
Empleados 1121

Símbolos bursátiles

Bolsa Símbolo
NASDAQ
TRUP
London Stock Exchange
0LH0.L
Frankfurt
TPW.F
Düsseldorf
TPW.DU
London
0LH0.L
SIX
TPW.SW
München
TPW.MU
🍪

Parqet  usa cookies. Más información